Electroporation-Mediated Immunization of a Candidate DNA Vaccine Expressing Dengue Virus Serotype 4 prM-E Antigen Confers Long-Term Protection in Mice

Virologica Sinica
Ziyang ShengJing An

Abstract

Dengue fever, caused by dengue viruses (DENVs), is a widespread mosquito-borne zoonotic disease; however, there is no available anti-dengue vaccine for worldwide use. In the current study, a DNA vaccine candidate (pV-D4ME) expressing prM-E protein of DENV serotype 4 (DENV-4) was constructed, and its immunogenicity and protection were evaluated in immunocompetent BALB/c mice. The pV-D4ME candidate vaccine induced effective humoral and cellular immunity of mice against DENV-4 in vivo when administered both at 50 μg and 5 μg through electroporation. Two weeks after receiving three immunizations, both doses of pV-D4ME DNA were shown to confer effective protection against lethal DENV-4 challenge. Notably, at 6 months after the three immunizations, 50 μg, but not 5 μg, of pV-D4ME could provide stable protection (100% survival rate) against DENV-4 lethal challenge without any obvious clinical signs. These results suggest that immunization with 50 μg pV-D4ME through electroporation could confer effective and long-term protection against DENV-4, offering a promising approach for development of a novel DNA vaccine against DENVs.

References

Sep 30, 1998·Lancet·J G Rigau-PérezA V Vorndam
Jul 20, 2010·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Suchitra Ranjit, Niranjan Kissoon
Nov 17, 2010·Nature Reviews. Microbiology·Maria G GuzmanRosanna W Peeling
Jan 5, 2011·Immunological Reviews·Margaret A Liu
May 3, 2011·Current Opinion in Immunology·Niranjan Y Sardesai, David B Weiner
Mar 24, 2012·Current Opinion in Virology·Natalie A HutnickDavid B Weiner
Apr 9, 2013·Nature·Samir BhattSimon I Hay
Jun 12, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Ola WeilandMatti Sällberg
Nov 10, 2013·PLoS Pathogens·Raphaël M ZellwegerSujan Shresta
Jan 1, 2014·Advances in Virus Research·Lauren E Yauch, Sujan Shresta
Jan 17, 2014·Germs·Kishwar Hayat Khan
Dec 10, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·John J SuschakShan Lu
Dec 31, 2014·Virologica Sinica·Jianchun WeiJing An
Jan 28, 2015·Human Vaccines & Immunotherapeutics·Benjamin YangChien-Fu Hung
Jul 28, 2015·The New England Journal of Medicine·Sri Rezeki HadinegoroUNKNOWN CYD-TDV Dengue Vaccine Working Group
Oct 16, 2015·Vaccine·Kevin R Porter, Kanakatte Raviprakash
Nov 19, 2015·Expert Opinion on Drug Delivery·Laure LambrichtGaëlle Vandermeulen
Sep 1, 2016·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Hui ChenJing An
Oct 4, 2016·The Journal of Infectious Diseases·Scott B Halstead
Feb 12, 2017·Vaccine· World Health Organization
Feb 12, 2017·The Lancet Infectious Diseases·Tikki PangDuane J Gubler
Jun 8, 2017·Nature Communications·Bryan D GriffinGary P Kobinger

❮ Previous
Next ❯

Citations

Apr 8, 2020·Frontiers in Cellular and Infection Microbiology·Kaihao FengJing An

❮ Previous
Next ❯

Datasets Mentioned

BETA
AY947539.1
AY648301.1

Methods Mentioned

BETA
PCR
Assay
ELISA

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.